Sarabia OR, García TJP, Amezcua RA

Language: Spanish
References: 10
Page: 486-492
PDF size: 232.93 Kb.

ABSTRACT

Background: Serous ovarian cystoadenofibroma is a relatively rare, slow-growing, benign epithelial neoplasm of unknown cause. Preoperative diagnosis is complex due to the absence of specific symptoms and signs to rule out malignancy.
Objective: To retrospectively analyze the clinical, radiologic, histopathologic features, and medical care of the patients.
Materials and Methods: Retrospective and descriptive analysis of patients with histopathological diagnosis of ovarian serous cystoadenofibroma attended at the General Hospital of Albacete between the years 2010 to 2022.
Results: 635 surgical specimens were analyzed, of which 57.74% corresponded to benign serous neoplasms, 17.41% to borderline serous neoplasms and 24.85% to malignant serous neoplasms. Twenty cases of patients with a diagnosis of ovarian serous cystoadenofibroma were identified. The mean age of these patients was 47 years, with limits of 9 and 74 years. One case was associated with a contralateral atypical serous proliferative atypical tumor. Treatment was surgical and no recurrences were identified in any of the cases.
Conclusions: Serous cystoadenofibroma usually manifests as a complex ovarian cyst, with solid-cystic components and irregular septa; this is why it is often misdiagnosed as a malignant tumor before surgery. Freeze biopsy helps to confirm its benign nature and avoids unnecessary extensive surgery. Treatment consists mainly of surgical removal of the cyst with or without oophorectomy. The prognosis is usually excellent.

REFERENCES

1. Fujita K, Ogawa C, Sako T, Utsumi F, Inada KI, Shibata K. A caseof ovarian serous cystadenofibroma with scattered lesionsin pelvic cavity, like malignant disseminations. J Obstet GynaecolRes 2021; 47 (12): 4496-501. doi:10.1111/jog.15018

2. George L, Mutter MD, Prat J. Pathology of the femalereproductive tract. 3th ed. Churchill Livingston-Elsevier,2014; 608-10.

3. Shurthi A, Sreelatha S, Bharathi A, Asha Devi L, Renuka R.A rare case of bilateral serous papillary cystadenofibroma.Arch Obstetric Gynecol Reprod Med 2018; 1 (1): 1-3.https://www.scitcentral.com/article/61/247/A-Rare-Caseof-Bilateral-Serous-Papillary-Cystadenofibroma

4. Fatum M, Rojansky N, Shushan A. Papillary serous cystadenofibromaof the ovary -is it really so rare? Int JGynaecol Obstet 2001; 75 (1): 85-6. doi:10.1016/s0020-7292(01)00415-5

5. Shukla S, Srivastava D, Acharya S, Dhote S, Vagha S. Serousadenofibroma of ovary: An eccentric presentation.J Cancer Res Ther 2015; 11 (4): 1030. doi: 10.4103/0973-1482.150419

6. Cho SM, Byun JY, Rha SE, Jung SE, Park GS, et al. CTand MRI findings of cystadenofibromas of the ovary.Eur Radiol 2004; 14 (5): 798-804. doi: 10.1007/s00330-003-2060-z

7. Jones AMK, Yue WY, Marcus J, Heller DS. Pitfalls of frozen sectionin gynecological pathology: a case of ovarian serous surfacepapillary adenofibroma imitating malignancy. Int J SurgPathol 2019; 27 (3): 268-70. doi:10.1177/1066896918818894

8. Takeuchi M, Matsuzaki K, Kusaka M, Shimazu H, YoshidaS, Nishitani H, Uehara H. Ovarian cystadenofibromas:characteristic magnetic resonance findings with pathologiccorrelation. J Comput Assist Tomogr 2003; 27 (6): 871-73.doi:10.1097/00004728-200311000-00007

9. Alcázar JL, Errasti T, Mínguez JA, Galán MJ, García-ManeroM, Ceamanos C. Sonographic features of ovarian cystadenofibromas:spectrum of findings. J Ultrasound Med 2001;20 (8): 915-9. doi:10.7863/jum.2001.20.8.915

10. Ghaemmaghami F, Karimi Zarchi M, Hamedi B. High levelsof CA125 (over 1,000 IU/ml) in patients with gynecologicdisease and non-malignant conditions: three cases andliterature review. Arch Gynecol Obstet 2007; 276 (5): 559-61. doi:10.1007/s00404-007-0381-x